Effects of Acute Ecklonia cava Supplementation on Submaximal Cycling and Repeated-Sprint Performance in Trained Cyclists: A Randomised Double-Blind Placebo-Controlled Crossover Trial
Nutrients · 2026
DOI: 10.3390/nu18203430 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Yunus Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery & Interventional Science, University College London, London WC1E 6BT, UK. Hauptthemen laut MEDLINE: Bicycling, Phaeophyceae, Athletic Performance, Dietary Supplements. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This study examined whether acute Ecklonia cava (EC) ingestion altered physiological responses during submaximal cycling or power output during subsequent repeated maximal sprints in experienced male cyclists.
Methods
Twelve cyclists completed a randomised, double-blind, placebo-controlled crossover trial. Participants ingested 263 mg of EC extract or placebo 30 min before 60 min of cycling at 55% of the maximum work rate, followed by three 20 s maximal sprints. Blood glucose, blood lactate, heart rate, oxygen uptake and respiratory exchange ratio (RER) were measured during submaximal cycling; peak power, mean power, blood glucose and blood lactate were assessed during the repeated-sprint test. Outcomes were analysed using linear mixed-effects models incorporating treatment, time, treatment × time, experimental period and allocated sequence.
Results
Blood glucose was higher overall following EC than placebo (4.23 ± 0.23 vs. 4.02 ± 0.33 mmol·L−1; mean difference, 0.213 mmol·L−1; 95% CI, 0.046 to 0.379; p = 0.023), but the treatment × time interaction was not significant (p = 0.939). EC did not affect submaximal blood lactate, heart rate, oxygen uptake or RER (all p ≥ 0.096). EC did not alter peak power (mean difference, −2.58 W; 95% CI, −29.51 to 24.35; p = 0.832), mean power (5.93 W; 95% CI, −2.47 to 14.33; p = 0.167), post-sprint glucose (p = 0.481) or post-sprint lactate (p = 0.060). No treatment × time interaction was identified for any repeated-sprint outcome (all p ≥ 0.267).
Conclusions
Acute ingestion of 263 mg of EC extract produced a modest overall elevation in blood glucose during submaximal cycling, but did not improve repeated-sprint performance or materially alter the other measured physiological responses. These findings do not support an acute ergogenic effect of EC in experienced male cyclists under the conditions tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Surgery & Interventional Science, University College London, London WC1E 6BT, UK.
- Department of Sport and Health Sciences, University of Exeter, Exeter EX4 4PY, UK.
- School of Life Sciences, Kingston University, Kingston upon Thames KT1 2EE, UK.
ORCID-Profile: Tom Gurney, James Brouner, Owen Spendiff
Zitieren
APA
Ali, Y., Gurney, T., Brouner, J., & Spendiff, O. (2026). Effects of Acute Ecklonia cava Supplementation on Submaximal Cycling and Repeated-Sprint Performance in Trained Cyclists: A Randomised Double-Blind Placebo-Controlled Crossover Trial. Nutrients. https://doi.org/10.3390/nu18203430
Vancouver
Ali Y, Gurney T, Brouner J, Spendiff O. Effects of Acute Ecklonia cava Supplementation on Submaximal Cycling and Repeated-Sprint Performance in Trained Cyclists: A Randomised Double-Blind Placebo-Controlled Crossover Trial. Nutrients. 2026. doi:10.3390/nu18203430
BibTeX
@article{Ali2026,
author = {Ali, Yunus and Gurney, Tom and Brouner, James and Spendiff, Owen},
title = {Effects of Acute Ecklonia cava Supplementation on Submaximal Cycling and Repeated-Sprint Performance in Trained Cyclists: A Randomised Double-Blind Placebo-Controlled Crossover Trial},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18203430}
}
EUVIMED